CAMP4 THERAPEUTICS Price To Earning vs. EBITDA
| CAMP Stock | USD 5.91 1.06 21.86% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.25 | 0.3597 |
|
|
For CAMP4 THERAPEUTICS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CAMP4 THERAPEUTICS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CAMP4 THERAPEUTICS PORATION utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CAMP4 THERAPEUTICS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CAMP4 THERAPEUTICS PORATION over time as well as its relative position and ranking within its peers.
CAMP4 |
CAMP4 THERAPEUTICS's Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CAMP4 THERAPEUTICS. If investors know CAMP4 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CAMP4 THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CAMP4 THERAPEUTICS is measured differently than its book value, which is the value of CAMP4 that is recorded on the company's balance sheet. Investors also form their own opinion of CAMP4 THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is CAMP4 THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CAMP4 THERAPEUTICS's market value can be influenced by many factors that don't directly affect CAMP4 THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CAMP4 THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if CAMP4 THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CAMP4 THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CAMP4 THERAPEUTICS EBITDA vs. Price To Earning Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining CAMP4 THERAPEUTICS's current stock value. Our valuation model uses many indicators to compare CAMP4 THERAPEUTICS value to that of its competitors to determine the firm's financial worth. CAMP4 THERAPEUTICS PORATION is rated third in price to earning category among its peers. It is rated below average in ebitda category among its peers . CAMP4 THERAPEUTICS reported last year EBITDA of (8.72 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value CAMP4 THERAPEUTICS by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.CAMP4 EBITDA vs. Price To Earning
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
CAMP4 THERAPEUTICS |
| = | 318.57 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
CAMP4 THERAPEUTICS |
| = | (8.72 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CAMP4 EBITDA Comparison
CAMP4 THERAPEUTICS is currently under evaluation in ebitda category among its peers.
CAMP4 THERAPEUTICS Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in CAMP4 THERAPEUTICS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CAMP4 THERAPEUTICS will eventually generate negative long term returns. The profitability progress is the general direction of CAMP4 THERAPEUTICS's change in net profit over the period of time. It can combine multiple indicators of CAMP4 THERAPEUTICS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.7 M | -1.8 M | |
| Operating Income | -8.7 M | -9.2 M | |
| Income Before Tax | -92.7 M | -88.1 M | |
| Total Other Income Expense Net | -84 M | -79.8 M | |
| Net Loss | -49.3 M | -51.8 M | |
| Income Tax Expense | -525 K | -498.8 K | |
| Net Interest Income | 2.8 M | 2 M | |
| Interest Income | 2.8 M | 2 M | |
| Net Loss | -49.3 M | -51.8 M | |
| Net Loss | (2.52) | (2.39) | |
| Income Quality | (0.15) | (0.14) | |
| Net Income Per E B T | 1.01 | 0.72 |
CAMP4 Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on CAMP4 THERAPEUTICS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CAMP4 THERAPEUTICS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CAMP4 THERAPEUTICS's important profitability drivers and their relationship over time.
Use CAMP4 THERAPEUTICS in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.CAMP4 THERAPEUTICS Pair Trading
CAMP4 THERAPEUTICS PORATION Pair Trading Analysis
The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.
The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your CAMP4 THERAPEUTICS position
In addition to having CAMP4 THERAPEUTICS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Municipals ETFs Thematic Idea Now
Broad Municipals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Municipals ETFs theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Municipals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.